Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma (Q42165114)

3

1 reference

17 October 2017

Takaaki Chou

4

1 reference

17 October 2017

Tetsuya Etoh

5

1 reference

17 October 2017

Masato Masuda

6

1 reference

17 October 2017

Fumio Kawano

7

1 reference

17 October 2017

Masao Matsuoka

8

1 reference

17 October 2017

Hirokuni Taguchi

9

1 reference

17 October 2017

Torahiko Makino

10

1 reference

17 October 2017

Yoshinobu Asano

11

1 reference

17 October 2017

Kazuo Tamura

12

1 reference

17 October 2017

Yasuo Ohashi

13

1 reference

17 October 2017

Cladribine/ATL Study Group, Japan

International Journal of Hematology

14

1 reference

17 October 2017

1 June 2003

1 reference

17 October 2017

1 reference

17 October 2017

77

1 reference

17 October 2017

512-517

1 reference

17 October 2017

5

1 reference

17 October 2017

https://scigraph.springernature.com/pub.10.1007/bf02986621

0 references

cites work

Arsenic trioxide inhibits growth of human T-cell leukaemia virus type I infected T-cell lines more effectively than retinoic acids

1 reference

12 December 2020

Eradication of virus-infected T-cells in a case of adult T-cell leukemia/lymphoma by nonmyeloablative peripheral blood stem cell transplantation with conditioning consisting of low-dose total body irradiation and pentostatin

1 reference

12 December 2020

2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma

1 reference

12 December 2020

The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia.

1 reference

12 December 2020

A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

1 reference

12 December 2020

Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.

1 reference

12 December 2020

Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo

1 reference

12 December 2020

Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimen.

1 reference

12 December 2020

An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support

1 reference

12 December 2020

Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).

1 reference

12 December 2020

2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia

1 reference

12 December 2020

Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease

1 reference

12 December 2020

Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: Possible role of nucleoside kinase(s)

1 reference

12 December 2020

Optimal two-stage designs for phase II clinical trials

1 reference

12 December 2020

Toxicity grading criteria of the Japan Clinical Oncology Group. The Clinical Trial Review Committee of the Japan Clinical Oncology Group

1 reference

12 December 2020

Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma

1 reference

12 December 2020

Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells

1 reference

12 December 2020

A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia

1 reference

12 December 2020

Rapid response of B-cell prolymphocytic leukemia to 2-chlorodeoxyadenosine

1 reference

12 December 2020

Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine

1 reference

12 December 2020

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes

1 reference

12 December 2020

Cladribine (2-chlorodeoxyadenosine)

1 reference

12 December 2020

Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M.

1 reference

12 December 2020

2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disorders

1 reference

12 December 2020

Adult T-cell leukemia-lymphoma successfully treated with 2-chlorodeoxyadenosine

1 reference

12 December 2020

Adult T-cell leukemia: clinical and hematologic features of 16 cases

1 reference

12 December 2020

Phase I study of YK-176 (2'-deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. The DCF Study Group

1 reference

12 December 2020

High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count

1 reference

12 December 2020

2-Chlorodeoxyadenosine treatment of low-grade lymphomas

1 reference

12 December 2020

Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group

1 reference

12 December 2020

Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

1 reference

12 December 2020

2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphoma

1 reference

12 December 2020

Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia

1 reference

12 December 2020

2-Chlorodeoxyadenosine activity in patients with untreated, indolent non-Hodgkin's lymphoma

1 reference

12 December 2020

Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the alpha-emitting radionuclide, bismuth 213.

1 reference

12 December 2020